UNSPSC 51323104: Colestolone

This classification denotes an anti-lipidemic agent with the molecular formula C27H44O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5P8396T5XF, chemically known as cl 274,471 but generally known as colestolone, which bears US NIH Compound Identifier 39756. European Medicines Agency schedules Colestolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06796MIG. The term COLESTOLONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29).

UNSPSC 51323104 Colestolone is a Commodity code encompassing pharmaceutical products and medications supplied to state and local health and human services agencies. State and local governments procure under this code to stock emergency medical supplies, pharmacy benefit programs, and health-system inventories. Recent solicitations show fire rescue services, state Medicaid and pharmacy benefit administrators, and multi-state cooperative purchasing alliances seeking branded or generic medications through sealed-bid, RFP, and RFI vehicles. The scope covers life-support medications (epinephrine, labetalol, adenosine, diltiazem), generic multi-source pharmaceuticals and over-the-counter products distributed through authorized wholesalers, and direct-to-manufacturer prescription fulfillment arrangements. Issuing bodies include municipal fire departments, state health and human services commissions, and regional cooperative purchasing consortia. Vendors must meet FDA compliance, cGMP certification, Drug Supply Chain Security Act (DSCSA) compliance, comprehensive product traceability through National Drug Codes (NDC), and Safety Data Sheets (SDSs) compliant with OSHA Hazard Communication Standards.

Geographic activity centers on Florida and Minnesota. The City of Tampa issued IFB No. 26P00188 on April 24, 2026, for advanced life support medications (labetalol, epinephrine, adenosine, diltiazem) to supply Tampa Fire Rescue in Hillsborough County, with an estimated contract value of $40,000 and a response deadline of April 8, 2026; the award carries a one-year term with two optional one-year renewals and a Small Local Business Enterprise (SLBE) 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson, with responses due March 26, 2026, and contract effectiveness July 1, 2026; MMCAP operates as a multi-state vehicle serving participating jurisdictions including Oregon. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for direct-to-manufacturer prescription programs without traditional pharmacy benefit manager intermediaries, signaling exploratory procurement intent ahead of a formal RFP.